Form 8-K - Current report:
SEC Accession No. 0001140361-25-003428
Filing Date
2025-02-06
Accepted
2025-02-06 16:05:38
Documents
13
Period of Report
2025-01-31
Items
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 8-K ef20042764_8k.htm   iXBRL 8-K 25201
  Complete submission text file 0001140361-25-003428.txt   158814

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tlry-20250131.xsd EX-101.SCH 3976
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlry-20250131_lab.xml EX-101.LAB 21966
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlry-20250131_pre.xml EX-101.PRE 16040
15 EXTRACTED XBRL INSTANCE DOCUMENT ef20042764_8k_htm.xml XML 4068
Mailing Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065
Business Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065 519.322.8800
Tilray Brands, Inc. (Filer) CIK: 0001731348 (see all company filings)

EIN.: 824310622 | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 001-38594 | Film No.: 25597359
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)